Suppr超能文献

在表达卵泡抑素和激活素的肿瘤中血管生成与肿瘤发生的解离

Dissociation of angiogenesis and tumorigenesis in follistatin- and activin-expressing tumors.

作者信息

Krneta Jelena, Kroll Jens, Alves Frauke, Prahst Claudia, Sananbenesi Farahnaz, Dullin Christian, Kimmina Sarah, Phillips David J, Augustin Hellmut G

机构信息

Department of Vascular Biology and Angiogenesis Research, Tumor Biology Center Freiburg, Freiburg, Germany.

出版信息

Cancer Res. 2006 Jun 1;66(11):5686-95. doi: 10.1158/0008-5472.CAN-05-3821.

Abstract

The transforming growth factor-beta superfamily member activin and its antagonist, follistatin, act as a pleiotropic growth factor system that controls cell proliferation, differentiation, and apoptosis. Activin inhibits fibroblast growth factor 2-induced sprouting angiogenesis in vitro (spheroidal angiogenesis assay) and in vivo (Matrigel assay). To further study the role of the activin/follistatin system during angiogenesis and tumor progression, activin- and follistatin-expressing R30C mammary carcinoma cells were studied in mouse tumor experiments. Surprisingly, activin-expressing tumors grew much faster than follistatin-expressing tumors although they failed to induce increased angiogenesis (as evidenced by low microvessel density counts). Conversely, follistatin-expressing tumors were much smaller but had a dense network of small-diameter capillaries. Qualitative angioarchitectural analyses (mural cell recruitment, perfusion) revealed no major functional differences of the tumor neovasculature. Analysis of activin- and follistatin-expressing R30C cells identified a cell autonomous role of this system in controlling tumor cell growth. Whereas proliferation of R30C cells was not altered, follistatin-expressing R30C cells had an enhanced susceptibility to undergo apoptosis. These findings in experimental tumors are complemented by an intriguing case report of a human renal cell carcinoma that similarly shows a dissociation of angiogenesis and tumorigenesis during tumor progression. Collectively, the data shed further light into the dichotomous stimulating and inhibiting roles that the activin/follistatin system can exert during angiogenesis and tumor progression. Furthermore, the experiments provide a critical proof-of-principle example for the dissociation of angiogenesis and tumorigenesis, supporting the concept that tumor growth may not be dependent on increased angiogenesis as long as a minimal intratumoral microvessel density is maintained.

摘要

转化生长因子-β超家族成员激活素及其拮抗剂卵泡抑素,作为一种多效生长因子系统,可控制细胞增殖、分化和凋亡。激活素在体外(球形血管生成试验)和体内(基质胶试验)均可抑制成纤维细胞生长因子2诱导的发芽血管生成。为了进一步研究激活素/卵泡抑素系统在血管生成和肿瘤进展过程中的作用,在小鼠肿瘤实验中对表达激活素和卵泡抑素的R30C乳腺癌细胞进行了研究。令人惊讶的是,表达激活素的肿瘤生长速度比表达卵泡抑素的肿瘤快得多,尽管它们未能诱导血管生成增加(微血管密度计数低证明了这一点)。相反,表达卵泡抑素的肿瘤要小得多,但有密集的小直径毛细血管网络。定性血管构筑分析(壁细胞募集、灌注)显示肿瘤新生血管没有主要功能差异。对表达激活素和卵泡抑素的R30C细胞的分析确定了该系统在控制肿瘤细胞生长中的细胞自主作用。虽然R30C细胞的增殖没有改变,但表达卵泡抑素的R30C细胞对凋亡的敏感性增强。实验肿瘤中的这些发现得到了一份有趣的人类肾细胞癌病例报告的补充,该报告同样显示了肿瘤进展过程中血管生成和肿瘤发生的分离。总体而言,这些数据进一步揭示了激活素/卵泡抑素系统在血管生成和肿瘤进展过程中可能发挥的二分刺激和抑制作用。此外,这些实验为血管生成和肿瘤发生的分离提供了一个关键的原理验证实例,支持了只要维持最小的肿瘤内微血管密度,肿瘤生长可能不依赖于血管生成增加的概念。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验